Global Interventional Cardiology Devices
Market Report
2024
Interventional Cardiology Devices Market Report 2024 (Global Edition)
Interventional cardiology devices market was valued at USD 17.2 billion in 2022 and will reach USD 32.31 billion by 2030, registering a CAGR of 8.2% for the forecast period 2023-2030.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
| Share your contact details to receive free updated sample copy/pages of the recently published edition of Interventional Cardiology Devices Market Report 2024.
Global Interventional Cardiology Devices Market Report 2024 Market Size Split by Product (Angioplasty Stents, Catheters, Angioplasty Balloons, Structural Heart Devices, Plaque Modification Devices, He...
The global interventional cardiology devices market was valued at USD 17.2 billion in 2022 and will reach USD 32.31 billion by 2030, registering a CAGR of 8.2% for the forecast period 2023-2030.
| Base Year | 2023 |
| Historical Data Time Period | 2019-2023 |
| Forecast Period | 2024-2031 |
| Global Interventional Cardiology Devices Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 8.2% |
| Market Split by Product |
|
| Market Split by Application |
|
| Market Split by End user |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Interventional Cardiology Devices industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Interventional Cardiology Devices Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Interventional Cardiology Devices Market Report Description
A subspecialty of cardiology known as interventional cardiology focuses on the catheter-based treatment of structural heart problems. Pacemakers, minute mesh tubes coated with medications, drug-eluting stents, and other devices are used in interventional cardiology. The avoidance of scars, pain, and a protracted post-operative recovery are the key benefits of employing an interventional cardiology or radiology method. Furthermore, primary angioplasty, an interventional cardiology technique, is currently the gold standard of therapy for acute myocardial infarction.
These types of cardiologists assist patients with vascular (blood vessel) and coronary (heart) ailments. Additionally, they support those with structural heart problems. These conditions include septal defects, which are irregularities in the walls dividing your heart chambers, and heart valve problems. Some interventional cardiologists devote their entire professional lives to treating infants and children with congenital (present at birth) heart conditions.
To do minimally invasive treatments on your heart or blood vessels, an interventional cardiologist uses catheters. This negates the necessity for a sternotomy, a significant incision. Open-heart surgery is not, however, something they do. Interventional cardiologists monitor cardiovascular functions including blood pressure and blood flow in significant arteries across the body and within the various heart chambers using a variety of diagnostic equipment and imaging techniques.
The growth of the interventional cardiology device market is fueled by various factors such as the rising prevalence of cardiovascular diseases and increasing advancement in interventional cardiology devices
Rising prevalence of cardiovascular diseases:
The increasing incidence of cardiovascular diseases such as coronary and peripheral arterial disease drives the interventional cardiology devices market due to the high consumption of tobacco, unhealthy diet, and less physical activity can lead to cardiovascular diseases. Interventional cardiology devices are used to treat various cardiovascular conditions such as adult congenital heart disease, coronary artery disease, valvular heart disease, atrial fibrillation, and peripheral vascular disease. Interventional cardiologists monitor cardiovascular functions including blood pressure and blood flow in significant arteries across the body and within the various heart chambers using a variety of diagnostic equipment and imaging techniques. Traditional "open" cardiac procedures are not carried out by interventional cardiologists, which increases the demand for interventional cardiology devices for the treatment of these diseases.
Increasing advancement in interventional cardiology devices:
One key market driver is the development of interventional cardiology device technologies. Technology-advanced imaging modalities like Optical Coherence Tomography (OCT), Fractional Flow Reserve (FFR), and Intravenous Ultrasound (IVUS) are covered by modern devices. Recent developments in the treatment of structural heart disease include the use of transcatheter aortic valve replacement (TAVR), transcatheter pulmonary valve replacement (TPVR), and transcatheter mitral valve repair (TMVR), as well as advanced 3D imaging for complex coronary and structural disease. Over the past several years, technological advancements have made it possible for us to assist a wider group of patients with complex cardiac and coronary anatomy.
The launch of new products and the increasing interest of competitors in this industry is expected to boost the growth of the interventional cardiology devices market. For instance, in July 2021 Medtronic Launched the Newest-Generation Drug-Coated Balloon Catheter in Europe for the Treatment of Coronary Artery Disease.
Restraining factors:
Complications associated with the use of interventional cardiology devices :
Complications related to the use of interventional cardiology tools, include radiation harm, myocardial infarction, and hematoma the use of interventional cardiology devices is hampered by coronary perforations, embolised device problems like coronary implant loss, particularly coronary stent dislodgement, lost scaffold, guidewire loss, and balloon fracture.
Additionally, In general, angioplasty with stenting is a safe technique. Even with the finest care, issues can still happen. Infection, bleeding, or bruising at the catheter site, an allergic reaction to the dye or contrast used, kidney damage from the dye, contrast, injury to the cardiac arteries, including rips, or rupture, and more are examples of complications. Blood clots that can cause a heart attack or stroke, as well as abdominal hemorrhage (retroperitoneal bleeding) all these complications can hamper the interventional cardiology devices.
Impact of COVID- 19 pandemic on the Interventional Cardiology Devices market:
The management of cardiac problems and the availability of cardiology services have both been greatly influenced by the 2019 Coronavirus Disease (COVID-19) pandemic. Due to the risk of infection transmission and the necessity to reallocate resources to deal with the rising number of COVID-19 patients, elective surgeries, outpatient appointments, and cardiac imaging have been substantially postponed around the world. During these times, the effects on patients with cardiac co-morbidities could be severe. However, cardiologists and hospitals all around the world have put policies in place to guarantee ongoing patient monitoring and care. social segregation policies, national blockades, and Even though the Department of Cardiology offers emergency and outpatient care, the number of hospital visits by patients has further decreased, which lowers sales of cardiac intervention devices and lowers the demand for cardiac intervention devices in some countries.
We have various report editions of Interventional Cardiology Devices Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Interventional Cardiology Devices Market Insights Video
May 2023:
Robotic platform R-One launched by Robocath
The debut of Robocath's most current robotic platform, R-One, has been announced. Robocath specializes in robotic treatments for cardiovascular disorders. An interventional cardiologist can conduct coronary angioplasties utilizing the robotic solution by operating equipment with an integrated control command unit.
May 2023:
Ucardia Announced Acquisition of Phas3, Launched Cardiologist Practice Remote Patient Monitoring Offering
The industry leader and pioneer in home-based cardiac rehab, Phas3, has agreed to be acquired by Ucardia, a software provider for cardiac conditioning. With this acquisition, physicians, payers, and consumers will have access to a comprehensive, industry-leading solution that will address all aspects of cardiac rehabilitation, conditioning, and remote monitoring for patients with cardiovascular disease (CVD).
November 2022:
Viz.ai announced a partnership with Us2.ai to Deliver AI-Enabled Echocardiography Decision Support with the Viz Platform
The provider of AI software that fully automates a whole echocardiogram or heart ultrasound, report, Us2.ai, has announced a cooperation with Viz.ai, the pioneer in AI-powered disease identification and intelligent care coordination. As part of the collaboration, Viz.ai makes Us2.ai's FDA- and CE-cleared echocardiography viewing and measurement tools available alongside the VizTM Platform to help patients with suspected heart disease, the top cause of death in the world, receive better and faster care coordination.
August 2022:
Medtronic announced that it has launched its newest drug-eluting coronary stent, the Onyx Frontier drug-eluting stent (DES), following recent CE Mark approval.
The Resolute Onyx drug-eluting stent's acute performance and clinical data are built upon by the Onyx Frontier DES, which also offers a novel delivery mechanism. The DES has the same best-in-class stent technology as Resolute Onyx DES. It has an improved delivery system1 that is intended to maximize acute performance in the most difficult situations and improve deliverability.
January 2022:
Medtronic Announced Approved Evolut PRO TAVR System.
The National Medical Products Administration (NMPA) for the treatment of severe aortic stenosis has approved the CoreValve Evolut PRO TAVR system (AS) in symptomatic patients who are at high or extremely high risk for open-heart surgery, according to Medtronic plc, a global leader in healthcare technology.
July 2021:
Medtronic Launched the Newest-Generation Drug-Coated Balloon Catheter in Europe for the Treatment of Coronary Artery Disease
The Prevail drug-coated balloon (DCB) Catheter was introduced in Europe after receiving the CE (Conformité Européene) designation from Medtronic plc, the world leader in medical technology. The Prevail DCB is the most recent coronary DCB on the market, and it is used during percutaneous coronary intervention (PCI) operations to treat blocked or restricted coronary arteries in people with coronary artery disease (CAD).
Top Companies Market Share in Interventional Cardiology Devices Industry: (In no particular order of Rank)
- Becton Dickson
- Boston Scientific Corporation.
- St. Jude Medical
- Medtronic
- Johnson & Johnson
- Edward Lifesciences Corporation.
- Getinge
- Abbott
- BIOTRONIK SE & Co. KG.
- W.L.Gore & Associates
- vascular
- Terumo Corporation
- Engologix
- B. BarunMelsungen
- Lepu Medical Technology
- Baxter
- Biosensors International Group
- Cardinal Health.
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
North America held the largest revenue market share over the other regions in the global interventional cardiology devices market:
The majority of global sales of interventional cardiology equipment are concentrated in North America. The increased prevalence of coronary artery diseases, ischemic heart disease, and vascular disease, the rise in awareness about the prompt use of the devices, technological developments in the field of cardiology and peripheral vascular devices, and favorable reimbursement policies are the main factors driving the growth of the North American interventional cardiology and peripheral vascular devices market. In addition, a growing elderly population that is susceptible to CVDs, as well as more product launches and approvals, will drive the market for interventional cardiology devices in the United States. The presence of cutting-edge medical facilities and a well-developed healthcare infrastructure, as well as the rising demand for minimally invasive surgeries among patients, rising government approvals for novel and innovative interventional cardiology devices, and are just a few of the additional factors anticipated to support market growth in the North American interventional cardiology devices market.
The current report Scope analyzes Interventional Cardiology Devices Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Interventional Cardiology Devices Market Share (%) by Region (2019-2031)
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Interventional Cardiology Devices Market Analysis
Global Interventional Cardiology Devices Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Interventional Cardiology Devices Industry growth. Interventional Cardiology Devices market has been segmented with the help of its Product, Application End user, and others. Interventional Cardiology Devices market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
By Product, the interventional cardiology devices market is segmented into Angioplasty Stents, Angioplasty Catheters, Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons, Structural Heart Devices, Hemodynamic Flow Alteration Devices, Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires, Endovascular Aneurysm, Repair Stent Grafts, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, and Other Product Types. Angioplasty Stents accounted large revenue share in the market.
A stent is a very small metal tube that maintains an artery open so that blood can flow through it more easily. After performing an angioplasty, which removes a buildup of plaque from inside your artery, your healthcare professional can implant a stent. Stents are long-lasting and help in preventing arteries from re-narrowing. There are three different rents. Biodegradable stents are drug-eluting and made entirely of metal. After your doctor removes an accumulation of plaque from inside your blood arteries, stents help your blood vessels function more effectively. Stents have several benefits, including the ability to improve blood flow through the artery where they are implanted, work in conjunction with angioplasty to stop a heart attack and lessen symptoms like shortness of breath and chest pain when a stent is implanted in your coronary artery. Furthermore, speed up recovery compared to people who undergo coronary artery bypass surgery. Because of all these factors, stents are widely used in angioplasty, which fuels market growth.
Angioplasty Stents
- Bioabsorbable Stents
- Drug-eluting Stents
- Bare-metal Stents
Catheters
- Angiography Catheters
- IVUS/OCT Catheters
- Guiding Catheters
Angioplasty Balloons
- Drug-eluting Balloons
- Old/Normal Balloons
- Cutting and Scoring Balloons
Structural Heart Devices
- Aortic Valve Therapy Devices
- pulmonary valve therapy devices
- Mitral valve therapy devices
- tricuspid valve therapy devices
- left atrial appendage therapy devices
- Other Therapy Devices
Plaque Modification Devices
- Atherectomy Devices
- Thrombectomy Devices
Hemodynamic Flow Alteration Devices
- Embolic Protection Devices
- Chronic Total Occlusion Devices
Other Devices
- Balloon Inflation Devices
- Hemostasis Valves
- Vascular Closure Devices
- Guidewires
- Introducer Sheaths
Interventional Cardiology Devices Market Share (%) by Product in 2019-2031
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Interventional Cardiology Devices Industry. Request a Free Sample PDF!
By Application, the interventional cardiology devices market is segmented into Angioplasty, Coronary Thrombectomy, Congenital Heart Defect Correction, Valvuloplasty, Percutaneous Valve Repair, and Others. Angioplasty held the largest revenue share in the interventional cardiology devices market.
A minimally invasive endovascular treatment called angioplasty, also known as balloon angioplasty and percutaneous transluminal angioplasty (PTA) is used to open up constricted or blocked veins or arteries, often as a means of treating arterial atherosclerosis. A better blood flow is made possible by the balloon's forced expansion of the blood artery and the surrounding muscle wall. To guarantee that the vessel stays open during ballooning, a stent is placed. The balloon is then withdrawn and deflated. The term "angioplasty" has come to refer to a wide range of percutaneous vascular treatments. A thin wire mesh tube known as a stent is frequently inserted in addition to an angioplasty. The stent aids in keeping the artery open, reducing the likelihood of further narrowing. Drug-eluting stents, which are common, are coated with medication to help keep the artery open. Bare-metal stents are used infrequently. Chest pain and shortness of breath are examples of symptoms of blocked arteries that can be improved by an angioplasty. Angioplasty is frequently done to unblock a clogged artery immediately during a heart attack and lessen the amount of damage to the heart. Due to all these features, angioplasty is highly demanded which fuels the market.
Interventional Cardiology Devices Market Share (%) by Application in 2019-2031
2019
2023
2031
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Interventional Cardiology Devices End user Segment Analysis
- Hospital
- Clinics
- ambulatory surgical centers
Author's Detail
Anushka GoreResearch Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the medical devices & consumables industry. She has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations.
In her current role, Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses. Her collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization.Anushka remains an invaluable asset in the dynamic landscape of market research.
Author's Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Interventional Cardiology Devices Market is witnessing significant growth in the near future.
In 2023, the Angioplasty Stents segment accounted for noticeable share of global Interventional Cardiology Devices Market and is projected to experience significant growth in the near future.
The Angioplasty segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Becton Dickson , St. Jude Medical and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Frequently Asked Questions
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Latest News about Interventional Cardiology Devices Market
Sources from Medical Devices & Consumables Industry
- http://www.trade.gov
- http://www.gov.uk
- http://www.fda.gov
- http://www.hhs.gov
- http://www.who.int
- http://www.bls.gov
- http://www.gao.gov
- http://www.ncbi.nlm.nih.gov
- http://www.healthcaredive.com
- http://www.weforum.org
- http://www.health.gov.za
- http://www.usaid.gov
- http://www.eumdr.com
- http://www.cdc.gov
- http://www.ama-assn.org
- http://www.washingtonpost.com
- http://www.ecfr.gov
- http://www.hbr.org
- http://www.worldbank.org
- http://www.commission.europa.eu
- http://www.cbi.eu
- http://www.unicef.org
- http://www.ecipe.org
- http://www.ema.europa.eu
Interventional Cardiology Devices Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Product | Angioplasty Stents, Catheters, Angioplasty Balloons, Structural Heart Devices, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Other Devices |
| Application | Angioplasty, Coronary Thrombectomy, Congenital Heart Defect Correction, Valvuloplasty, Percutaneous Valve Repair, Other |
| End user | Hospital, Clinics, ambulatory surgical centers |
| List of Competitors | Becton Dickson, Boston Scientific Corporation., St. Jude Medical, Medtronic, Johnson & Johnson, Edward Lifesciences Corporation., Getinge, Abbott, BIOTRONIK SE & Co. KG., W.L.Gore & Associates, vascular, Terumo Corporation, Engologix, B. BarunMelsungen, Lepu Medical Technology, Baxter, Biosensors International Group, Cardinal Health. |
This chapter will help you gain GLOBAL Market Analysis of Interventional Cardiology Devices. Further deep in this chapter, you will be able to review Global Interventional Cardiology Devices Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global Interventional Cardiology Devices Market Size, Trend Analysis 2019 - 2031
-
1.2 Global Interventional Cardiology Devices Market Size By Regions 2019 - 2031
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global Interventional Cardiology Devices Revenue Market Size By Region
-
-
1.3 Global Interventional Cardiology Devices Market Size By Product 2019 -2031
-
1.3.1 Angioplasty Stents Market Size
-
1.3.2 Catheters Market Size
-
1.3.3 Angioplasty Balloons Market Size
-
1.3.4 Structural Heart Devices Market Size
-
1.3.5 Plaque Modification Devices Market Size
-
1.3.6 Hemodynamic Flow Alteration Devices Market Size
-
1.3.7 Other Devices Market Size
-
-
1.4 Global Interventional Cardiology Devices Market Size By Application 2019 -2031
-
1.4.1 Angioplasty Market Size
-
1.4.2 Coronary Thrombectomy Market Size
-
1.4.3 Congenital Heart Defect Correction Market Size
-
1.4.4 Valvuloplasty Market Size
-
1.4.5 Percutaneous Valve Repair Market Size
-
1.4.6 Other Market Size
-
-
1.5 Global Interventional Cardiology Devices Market Size By End user 2019 -2031
-
1.5.1 Hospital Market Size
-
1.5.2 Clinics Market Size
-
1.5.3 ambulatory surgical centers Market Size
-
-
1.6 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.7 Executive Summary Global Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.7.1 Regional Market Revenue Summary 2019 vs 2024 vs 2031
-
1.7.2 Global Market Revenue Split By Product
-
1.7.3 Global Market Revenue Split By Application
-
1.7.4 Global Market Revenue Split By End user
-
1.7.5 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
Chapter 2 North America Market Analysis
-
2.1 North America Interventional Cardiology Devices Market Size 2019 - 2031
-
2.1.1 North America Interventional Cardiology Devices Market Size By Country 2019 - 2031
-
2.1.2 North America Interventional Cardiology Devices Market Size by Product 2019 -2031
-
2.1.2.1 North America Angioplasty Stents Market Size
-
2.1.2.2 North America Catheters Market Size
-
2.1.2.3 North America Angioplasty Balloons Market Size
-
2.1.2.4 North America Structural Heart Devices Market Size
-
2.1.2.5 North America Plaque Modification Devices Market Size
-
2.1.2.6 North America Hemodynamic Flow Alteration Devices Market Size
-
2.1.2.7 North America Other Devices Market Size
-
-
2.1.3 North America Interventional Cardiology Devices Market Size by Application 2019 -2031
-
2.1.3.1 North America Angioplasty Market Size
-
2.1.3.2 North America Coronary Thrombectomy Market Size
-
2.1.3.3 North America Congenital Heart Defect Correction Market Size
-
2.1.3.4 North America Valvuloplasty Market Size
-
2.1.3.5 North America Percutaneous Valve Repair Market Size
-
2.1.3.6 North America Other Market Size
-
-
2.1.4 North America Interventional Cardiology Devices Market Size by End user 2019 -2031
-
2.1.4.1 North America Hospital Market Size
-
2.1.4.2 North America Clinics Market Size
-
2.1.4.3 North America ambulatory surgical centers Market Size
-
-
Chapter 3 Europe Market Analysis
-
3.1 Europe Interventional Cardiology Devices Market Size 2019 - 2031
-
3.1.1 Europe Interventional Cardiology Devices Market Size By Country 2019 - 2031
-
3.1.2 Europe Interventional Cardiology Devices Market Size by Product 2019 -2031
-
3.1.2.1 Europe Angioplasty Stents Market Size
-
3.1.2.2 Europe Catheters Market Size
-
3.1.2.3 Europe Angioplasty Balloons Market Size
-
3.1.2.4 Europe Structural Heart Devices Market Size
-
3.1.2.5 Europe Plaque Modification Devices Market Size
-
3.1.2.6 Europe Hemodynamic Flow Alteration Devices Market Size
-
3.1.2.7 Europe Other Devices Market Size
-
-
3.1.3 Europe Interventional Cardiology Devices Market Size by Application 2019 -2031
-
3.1.3.1 Europe Angioplasty Market Size
-
3.1.3.2 Europe Coronary Thrombectomy Market Size
-
3.1.3.3 Europe Congenital Heart Defect Correction Market Size
-
3.1.3.4 Europe Valvuloplasty Market Size
-
3.1.3.5 Europe Percutaneous Valve Repair Market Size
-
3.1.3.6 Europe Other Market Size
-
-
3.1.4 Europe Interventional Cardiology Devices Market Size by End user 2019 -2031
-
3.1.4.1 Europe Hospital Market Size
-
3.1.4.2 Europe Clinics Market Size
-
3.1.4.3 Europe ambulatory surgical centers Market Size
-
-
Chapter 4 Asia Pacific Market Analysis
-
4.1 Asia Pacific Interventional Cardiology Devices Market Size 2019 - 2031
-
4.1.1 Asia Pacific Interventional Cardiology Devices Market Size By Country 2019 - 2031
-
4.1.2 Asia Pacific Interventional Cardiology Devices Market Size by Product 2019 -2031
-
4.1.2.1 Asia Pacific Angioplasty Stents Market Size
-
4.1.2.2 Asia Pacific Catheters Market Size
-
4.1.2.3 Asia Pacific Angioplasty Balloons Market Size
-
4.1.2.4 Asia Pacific Structural Heart Devices Market Size
-
4.1.2.5 Asia Pacific Plaque Modification Devices Market Size
-
4.1.2.6 Asia Pacific Hemodynamic Flow Alteration Devices Market Size
-
4.1.2.7 Asia Pacific Other Devices Market Size
-
-
4.1.3 Asia Pacific Interventional Cardiology Devices Market Size by Application 2019 -2031
-
4.1.3.1 Asia Pacific Angioplasty Market Size
-
4.1.3.2 Asia Pacific Coronary Thrombectomy Market Size
-
4.1.3.3 Asia Pacific Congenital Heart Defect Correction Market Size
-
4.1.3.4 Asia Pacific Valvuloplasty Market Size
-
4.1.3.5 Asia Pacific Percutaneous Valve Repair Market Size
-
4.1.3.6 Asia Pacific Other Market Size
-
-
4.1.4 Asia Pacific Interventional Cardiology Devices Market Size by End user 2019 -2031
-
4.1.4.1 Asia Pacific Hospital Market Size
-
4.1.4.2 Asia Pacific Clinics Market Size
-
4.1.4.3 Asia Pacific ambulatory surgical centers Market Size
-
-
Chapter 5 South America Market Analysis
-
5.1 South America Interventional Cardiology Devices Market Size 2019 - 2031
-
5.1.1 South America Interventional Cardiology Devices Market Size By Country 2019 - 2031
-
5.1.2 South America Interventional Cardiology Devices Market Size by Product 2019 -2031
-
5.1.2.1 South America Angioplasty Stents Market Size
-
5.1.2.2 South America Catheters Market Size
-
5.1.2.3 South America Angioplasty Balloons Market Size
-
5.1.2.4 South America Structural Heart Devices Market Size
-
5.1.2.5 South America Plaque Modification Devices Market Size
-
5.1.2.6 South America Hemodynamic Flow Alteration Devices Market Size
-
5.1.2.7 South America Other Devices Market Size
-
-
5.1.3 South America Interventional Cardiology Devices Market Size by Application 2019 -2031
-
5.1.3.1 South America Angioplasty Market Size
-
5.1.3.2 South America Coronary Thrombectomy Market Size
-
5.1.3.3 South America Congenital Heart Defect Correction Market Size
-
5.1.3.4 South America Valvuloplasty Market Size
-
5.1.3.5 South America Percutaneous Valve Repair Market Size
-
5.1.3.6 South America Other Market Size
-
-
5.1.4 South America Interventional Cardiology Devices Market Size by End user 2019 -2031
-
5.1.4.1 South America Hospital Market Size
-
5.1.4.2 South America Clinics Market Size
-
5.1.4.3 South America ambulatory surgical centers Market Size
-
-
Chapter 6 Middle East and Africa Market Analysis
-
6.1 Middle East and Africa Interventional Cardiology Devices Market Size 2019 - 2031
-
6.1.1 Middle East and Africa Interventional Cardiology Devices Market Size By Country 2019 - 2031
-
6.1.2 Middle East and Africa Interventional Cardiology Devices Market Size by Product 2019 -2031
-
6.1.2.1 Middle East and Africa Angioplasty Stents Market Size
-
6.1.2.2 Middle East and Africa Catheters Market Size
-
6.1.2.3 Middle East and Africa Angioplasty Balloons Market Size
-
6.1.2.4 Middle East and Africa Structural Heart Devices Market Size
-
6.1.2.5 Middle East and Africa Plaque Modification Devices Market Size
-
6.1.2.6 Middle East and Africa Hemodynamic Flow Alteration Devices Market Size
-
6.1.2.7 Middle East and Africa Other Devices Market Size
-
-
6.1.3 Middle East and Africa Interventional Cardiology Devices Market Size by Application 2019 -2031
-
6.1.3.1 middle_east_and_africa_title} Angioplasty Market Size
-
6.1.3.2 middle_east_and_africa_title} Coronary Thrombectomy Market Size
-
6.1.3.3 middle_east_and_africa_title} Congenital Heart Defect Correction Market Size
-
6.1.3.4 middle_east_and_africa_title} Valvuloplasty Market Size
-
6.1.3.5 middle_east_and_africa_title} Percutaneous Valve Repair Market Size
-
6.1.3.6 middle_east_and_africa_title} Other Market Size
-
-
6.1.4 Middle East and Africa Interventional Cardiology Devices Market Size by End user 2019 -2031
-
6.1.4.1 Middle East and Africa Hospital Market Size
-
6.1.4.2 Middle East and Africa Clinics Market Size
-
6.1.4.3 Middle East and Africa ambulatory surgical centers Market Size
-
-
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis (Only Available with Corporate User License)
-
7.1 Country 1 Market Analysis
-
7.1.1 Country 1Interventional Cardiology Devices Market Size by Product 2019 -2031
-
7.1.2 Country 1Interventional Cardiology Devices Market Size by Application 2019 -2031
-
7.1.3 Country 1Interventional Cardiology Devices Market Size by End user 2019 -2031
-
-
7.2 Country 2 Market Analysis
-
7.2.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.3 Country 3 Market Analysis
-
7.3.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.4 Country 4 Market Analysis
-
7.4.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.5 Country 5 Market Analysis
-
7.5.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.6 Country 6 Market Analysis
-
7.6.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.7 Country 7 Market Analysis
-
7.7.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.8 Country 8 Market Analysis
-
7.8.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.9 Country 9 Market Analysis
-
7.9.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.10 Country 10 Market Analysis
-
7.10.1 Segmentation Analysis will be provided as shown for Country 1
-
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2022
-
8.1.2 Global Interventional Cardiology Devices Market Revenue and Share by Manufacturers (2019-2023)
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability)
-
8.2.1 Becton Dickson
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 Boston Scientific Corporation.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 St. Jude Medical
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 Medtronic
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 Johnson & Johnson
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 Edward Lifesciences Corporation.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 Getinge
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
8.2.8 Abbott
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.8.2 Business Overview
-
8.2.8.3 Financials (Subject to data availability)
-
8.2.8.4 Product Types Specification
-
8.2.8.5 Business Strategy
-
8.2.8.6 S.W.O.TAnalysis
-
-
8.2.9 BIOTRONIK SE & Co. KG.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.9.2 Business Overview
-
8.2.9.3 Financials (Subject to data availability)
-
8.2.9.4 Product Types Specification
-
8.2.9.5 Business Strategy
-
8.2.9.6 S.W.O.TAnalysis
-
-
8.2.10 W.L.Gore & Associates
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.10.2 Business Overview
-
8.2.10.3 Financials (Subject to data availability)
-
8.2.10.4 Product Types Specification
-
8.2.10.5 Business Strategy
-
8.2.10.6 S.W.O.TAnalysis
-
-
8.2.11 vascular
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.11.2 Business Overview
-
8.2.11.3 Financials (Subject to data availability)
-
8.2.11.4 Product Types Specification
-
8.2.11.5 Business Strategy
-
8.2.11.6 S.W.O.TAnalysis
-
-
8.2.12 Terumo Corporation
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.12.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.12.2 Business Overview
-
8.2.12.3 Financials (Subject to data availability)
-
8.2.12.4 Product Types Specification
-
8.2.12.5 Business Strategy
-
8.2.12.6 S.W.O.TAnalysis
-
-
8.2.13 Engologix
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.13.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.13.2 Business Overview
-
8.2.13.3 Financials (Subject to data availability)
-
8.2.13.4 Product Types Specification
-
8.2.13.5 Business Strategy
-
8.2.13.6 S.W.O.TAnalysis
-
-
8.2.14 B. BarunMelsungen
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.14.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.14.2 Business Overview
-
8.2.14.3 Financials (Subject to data availability)
-
8.2.14.4 Product Types Specification
-
8.2.14.5 Business Strategy
-
8.2.14.6 S.W.O.TAnalysis
-
-
8.2.15 Lepu Medical Technology
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.15.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.15.2 Business Overview
-
8.2.15.3 Financials (Subject to data availability)
-
8.2.15.4 Product Types Specification
-
8.2.15.5 Business Strategy
-
8.2.15.6 S.W.O.TAnalysis
-
-
8.2.16 Baxter
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.16.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.16.2 Business Overview
-
8.2.16.3 Financials (Subject to data availability)
-
8.2.16.4 Product Types Specification
-
8.2.16.5 Business Strategy
-
8.2.16.6 S.W.O.TAnalysis
-
-
8.2.17 Biosensors International Group
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.17.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.17.2 Business Overview
-
8.2.17.3 Financials (Subject to data availability)
-
8.2.17.4 Product Types Specification
-
8.2.17.5 Business Strategy
-
8.2.17.6 S.W.O.TAnalysis
-
-
8.2.18 Cardinal Health.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.18.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.18.2 Business Overview
-
8.2.18.3 Financials (Subject to data availability)
-
8.2.18.4 Product Types Specification
-
8.2.18.5 Business Strategy
-
8.2.18.6 S.W.O.TAnalysis
-
-
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Market Drivers
-
9.2 Market Trends
-
9.3 Market Restraints
-
9.4 Market Opportunity
-
9.5 Product Life Cycle (Subject to Data Availability)
-
9.6 Industrial Chain Analysis (Subject to Data Availability)
-
9.6.1 Industry Chain Analysis
-
9.6.2 Manufacturing Cost Analysis
-
9.6.3 Consumer Preference Analysis
-
9.6.4 Supply Side Analysis
-
9.6.4.1 Raw Material Analysis
-
9.6.4.2 Raw Material Procurement Analysis
-
9.6.4.3 Raw Material Price Trend Analysis
-
-
-
9.7 Market Attractiveness Analysis
-
9.8 PESTEL Analysis
-
9.9 Porter’s Five Forces Analysis
-
9.10 Patent Analysis (Subject to Data Availability)
-
9.11 ESG Analysis
-
9.12 Technological Road Map
Segmentation Product Analysis 2019 -2031, will provide market size split by Product. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Product Analysis 2019 -2031
-
10.1 Angioplasty Stents
-
10.1.1 Global Interventional Cardiology Devices Revenue Market Size and Share by Angioplasty Stents 2019 -2031
-
-
10.2 Catheters
-
10.2.1 Global Interventional Cardiology Devices Revenue Market Size and Share by Catheters 2019 -2031
-
-
10.3 Angioplasty Balloons
-
10.3.1 Global Interventional Cardiology Devices Revenue Market Size and Share by Angioplasty Balloons 2019 -2031
-
-
10.4 Structural Heart Devices
-
10.4.1 Global Interventional Cardiology Devices Revenue Market Size and Share by Structural Heart Devices 2019 -2031
-
-
10.5 Plaque Modification Devices
-
10.5.1 Global Interventional Cardiology Devices Revenue Market Size and Share by Plaque Modification Devices 2019 -2031
-
-
10.6 Hemodynamic Flow Alteration Devices
-
10.6.1 Global Interventional Cardiology Devices Revenue Market Size and Share by Hemodynamic Flow Alteration Devices 2019 -2031
-
-
10.7 Other Devices
-
10.7.1 Global Interventional Cardiology Devices Revenue Market Size and Share by Other Devices 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Analysis 2019 -2031
-
11.1 Angioplasty
-
11.1.1 Global Interventional Cardiology Devices Revenue Market Size and Share by Angioplasty 2019 - 2031
-
-
11.2 Coronary Thrombectomy
-
11.2.1 Global Interventional Cardiology Devices Revenue Market Size and Share by Coronary Thrombectomy 2019 - 2031
-
-
11.3 Congenital Heart Defect Correction
-
11.3.1 Global Interventional Cardiology Devices Revenue Market Size and Share by Congenital Heart Defect Correction 2019 - 2031
-
-
11.4 Valvuloplasty
-
11.4.1 Global Interventional Cardiology Devices Revenue Market Size and Share by Valvuloplasty 2019 - 2031
-
-
11.5 Percutaneous Valve Repair
-
11.5.1 Global Interventional Cardiology Devices Revenue Market Size and Share by Percutaneous Valve Repair 2019 - 2031
-
-
11.6 Other
-
11.6.1 Global Interventional Cardiology Devices Revenue Market Size and Share by Other 2019 - 2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by End user Analysis 2019 -2031
-
12.1 Hospital
-
12.1.1 Global Interventional Cardiology Devices Revenue Market Size and Share by Hospital 2019 -2031
-
-
12.2 Clinics
-
12.2.1 Global Interventional Cardiology Devices Revenue Market Size and Share by Clinics 2019 -2031
-
-
12.3 ambulatory surgical centers
-
12.3.1 Global Interventional Cardiology Devices Revenue Market Size and Share by ambulatory surgical centers 2019 -2031
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Interventional Cardiology Devices market
Chapter 13 Research Findings
-
13.1 Key Takeaways
-
13.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
13.3 Assumptions and Acronyms
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Research Methodology Implemented by Anushka Gore and Team
- 1.1 Interventional Cardiology Devices Market Report 2024 Research Methodology
- 1.2 Systematic Research Approach
- 1.2.1 Primary Research for Interventional Cardiology Devices Market
- 1.2.1.1 Key Data from Primary
- 1.2.1.2 Primary Interviews with Experts
- 1.2.1.3 Key Industry Insights
- 1.2.1.4 Questionnaire for Interventional Cardiology Devices Market
- 1.2.1.5 Breakdown of Primaries
- 1.2.2 Secondary Research for Interventional Cardiology Devices Market
- 1.2.2.1 Key Data from Secondary
- 1.2.2.2 Paid Sources
- 1.2.2.3 Public Sources
- 1.3 Market Size Estimation for Interventional Cardiology Devices Market
- 1.3.1 Top-Down Approach
- 1.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 1.3.2 Bottom-UP Approach
- 1.3.2.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 1.3.1 Top-Down Approach
- 1.4 Market Breakdown and Data Triangulation
- 1.5 Research Assumptions for Interventional Cardiology Devices Market
Key Questions Answered By Interventional Cardiology Devices Market Report 2024
| Why Angioplasty Stents have a significant impact on Interventional Cardiology Devices market? |
| What are the key factors affecting the Angioplasty Stents and Catheters of Interventional Cardiology Devices Market? |
| What is the CAGR/Growth Rate of Angioplasty during the forecast period? |
| By type, which segment accounted for largest share of the global Interventional Cardiology Devices Market? |
| Which region is expected to dominate the global Interventional Cardiology Devices Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
